{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T06:55:07Z","timestamp":1678085707742},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.043","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T16:01:20Z","timestamp":1460390480000},"page":"1705-1712","source":"Crossref","is-referenced-by-count":2,"title":["A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack"],"prefix":"10.1016","volume":"25","author":[{"given":"Jin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter N.","family":"Kernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4158\/EP.9.S2.5","article-title":"American College of Endocrinology position statement on the insulin resistance syndrome","volume":"9","author":"Einhorn","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0015","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/STROKEAHA.108.539650","article-title":"Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria","volume":"40","author":"Hyvarinen","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/WNL.59.6.809","article-title":"Insulin resistance and risk for stroke","volume":"59","author":"Kernan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0025","doi-asserted-by":"crossref","first-page":"e3564","DOI":"10.1136\/bmj.e3564","article-title":"Effect of pre-diabetes on future risk of stroke: meta-analysis","volume":"344","author":"Lee","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0030","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","article-title":"HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study","volume":"25","author":"Bonora","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0035","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0040","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.metabol.2004.05.017","article-title":"Comparative evaluation of simple indices of insulin resistance","volume":"53","author":"Vaccaro","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diacare.24.3.460","article-title":"Diagnosing insulin resistance in the general population","volume":"24","author":"McAuley","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0050","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00125-014-3285-x","article-title":"Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis","volume":"57","author":"Otten","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-151-5-200909010-00004","article-title":"Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial","volume":"151","author":"Esposito","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes","volume":"54","author":"Petersen","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0070","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0075","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0080","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ahj.2007.11.029","article-title":"Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10)","volume":"155","author":"Wilcox","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0085","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after Ischemic Stroke or Transient Ischemic Attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0090","series-title":"Multivariable analysis: a practical guide for clinicians and public health researchers","author":"Katz","year":"2011"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ajcn\/83.1.47","article-title":"Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults","volume":"83","author":"Farin","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0100","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.2337\/dc07-0360","article-title":"Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men","volume":"30","author":"Riserus","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0105","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0735-1097(02)02051-X","article-title":"Relationship between obesity, insulin resistance, and coronary heart disease risk","volume":"40","author":"Abbasi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0115","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"63","author":"Jensen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00132577-200512000-00018","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement: executive summary","volume":"4","author":"Grundy","year":"2005","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0125","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1464-5491.2004.01298.x","article-title":"IRIS II study: the IRIS II score\u2014assessment of a new clinical algorithm for the classification of insulin resistance in patients with type 2 diabetes","volume":"21","author":"Forst","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2337\/diabetes.54.2.333","article-title":"Identification of individuals with insulin resistance using routine clinical measurements","volume":"54","author":"Stern","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity","volume":"23","author":"Bonora","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0145","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2337\/diab.41.12.1575","article-title":"The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents","volume":"41","author":"Gulli","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0150","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/diab.45.7.947","article-title":"Insulin action and age. European Group for the Study of Insulin Resistance (EGIR)","volume":"45","author":"Ferrannini","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.03.043_bib0155","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/diab.36.11.1329","article-title":"In vivo insulin action is familial characteristic in nondiabetic Pima Indians","volume":"36","author":"Lillioja","year":"1987","journal-title":"Diabetes"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716001968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716001968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T16:36:40Z","timestamp":1655483800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305716001968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1052305716001968"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.03.043","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}